Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Precision Biosciences Inc (DTIL)
since 2019 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Precision Biosciences Inc.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1357874.
Total stock buying since 2019: $2,004,457.
Total stock sales since 2019: $4,863,674.
Total stock option exercises since 2019: $494,661.
Table 3. Detailed insider trading at Precision Biosciences Inc (DTIL)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-07-03 | Kelly John Alexander (Chief Financial Officer) | Sale | 14,827 | 4.26 | 63,163 |
| 2025-06-25 | Buehler Kevin (Director) | Buy | 5,076 | 4.16 | 21,116 |
| 2025-06-25 | Brown Melinda (Director) | Buy | 1,682 | 4.14 | 6,963 |
| 2025-05-27 | Pire Shari Lisa | Option Ex | 9,826 | .00 | 0 |
| 2025-05-27 | Germano Geno J | Option Ex | 9,826 | .00 | 0 |
| 2025-03-26 | Buehler Kevin | Buy | 4,523 | 4.67 | 21,122 |
| 2025-03-26 | Brown Melinda | Buy | 1,839 | 4.75 | 8,735 |
| 2025-03-25 | Germano Geno J | Buy | 3,250 | 5.30 | 17,225 |
| 2025-03-24 | Amoroso Michael (President and CEO) | Sale | 964 | 5.56 | 5,359 |
| 2025-03-21 | Amoroso Michael (President and CEO) | Option Ex | 3,417 | .00 | 0 |
| 2025-03-04 | Scimeca Dario (General Counsel and Secretary) | Sale | 272 | 4.91 | 1,335 |
| 2025-03-04 | Smith J. Jefferson (Chief Research Officer) | Sale | 154 | 4.91 | 756 |
| 2025-03-03 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 919 | .00 | 0 |
| 2025-03-03 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 519 | .00 | 0 |
| 2025-03-03 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 1,702 | .00 | 0 |
| 2025-01-22 | Scimeca Dario (General Counsel and Secretary) | Sale | 8,928 | 4.79 | 42,765 |
| 2025-01-22 | Smith J. Jefferson (Chief Research Officer) | Sale | 10,287 | 4.79 | 49,274 |
| 2025-01-21 | Amoroso Michael (President and CEO) | Sale | 36,838 | 4.67 | 172,033 |
| 2025-01-20 | Amoroso Michael (President and CEO) | Option Ex | 115,388 | .00 | 0 |
| 2025-01-20 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 25,312 | .00 | 0 |
| 2025-01-20 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 29,168 | .00 | 0 |
| 2025-01-20 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 44,368 | .00 | 0 |
| 2024-11-21 | Kelly John Alexander (Chief Financial Officer) | Buy | 3,000 | 6.76 | 20,280 |
| 2024-11-04 | Amoroso Michael (President and CEO) | Sale | 3,012 | 8.19 | 24,668 |
| 2024-11-04 | Scimeca Dario (General Counsel and Secretary) | Sale | 588 | 8.19 | 4,815 |
| 2024-11-02 | Amoroso Michael (President and CEO) | Option Ex | 9,443 | .00 | 0 |
| 2024-11-02 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 1,836 | .00 | 0 |
| 2024-11-02 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 3,605 | .00 | 0 |
| 2024-06-10 | Scimeca Dario (General Counsel and Secretary) | Sale | 93 | 11.79 | 1,096 |
| 2024-06-10 | Smith J. Jefferson (Chief Research Officer) | Sale | 50 | 11.79 | 589 |
| 2024-06-07 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 301 | .00 | 0 |
| 2024-06-07 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 163 | .00 | 0 |
| 2024-06-07 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 454 | .00 | 0 |
| 2024-05-04 | Pire Shari Lisa | Option Ex | 4,202 | .00 | 0 |
| 2024-05-04 | Frankel Stanley | Option Ex | 4,202 | .00 | 0 |
| 2024-05-04 | Buehler Kevin | Option Ex | 4,202 | .00 | 0 |
| 2024-05-04 | Brown Melinda | Option Ex | 4,202 | .00 | 0 |
| 2024-05-04 | Wadsworth Samuel C. | Option Ex | 4,202 | .00 | 0 |
| 2024-05-04 | Germano Geno J | Option Ex | 4,202 | .00 | 0 |
| 2024-05-02 | List Alan (Chief Medical Officer) | Sale | 290 | 10.32 | 2,992 |
| 2024-05-02 | Amoroso Michael (President and CEO) | Sale | 1,526 | 10.32 | 15,748 |
| 2024-05-02 | Scimeca Dario (General Counsel and Secretary) | Sale | 272 | 10.32 | 2,807 |
| 2024-05-02 | Smith J. Jefferson (Chief Research Officer) | Sale | 154 | 10.32 | 1,589 |
| 2024-05-01 | List Alan (Chief Medical Officer) | Option Ex | 982 | .00 | 0 |
| 2024-05-01 | Amoroso Michael (President and CEO) | Option Ex | 3,417 | .00 | 0 |
| 2024-05-01 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 918 | .00 | 0 |
| 2024-05-01 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 519 | .00 | 0 |
| 2024-05-01 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 1,702 | .00 | 0 |
| 2024-01-23 | Smith J. Jefferson (Chief Research Officer) | Sale | 28,000 | .37 | 10,360 |
| 2024-01-22 | List Alan (Chief Medical Officer) | Sale | 21,526 | .36 | 7,749 |
| 2024-01-22 | Amoroso Michael (President and CEO) | Sale | 137,390 | .36 | 49,460 |
| 2024-01-22 | Scimeca Dario (General Counsel and Secretary) | Sale | 21,287 | .36 | 7,663 |
| 2024-01-20 | List Alan (Chief Medical Officer) | Option Ex | 60,012 | .00 | 0 |
| 2024-01-20 | Amoroso Michael (President and CEO) | Option Ex | 266,720 | .00 | 0 |
| 2024-01-20 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 59,345 | .00 | 0 |
| 2024-01-20 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 75,015 | .00 | 0 |
| 2024-01-20 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 116,690 | .00 | 0 |
| 2023-11-03 | Amoroso Michael (President and CEO) | Sale | 125,025 | .40 | 50,010 |
| 2023-11-03 | Scimeca Dario (General Counsel and Secretary) | Sale | 16,023 | .40 | 6,409 |
| 2023-11-02 | Amoroso Michael (President and CEO) | Option Ex | 283,390 | .00 | 0 |
| 2023-11-02 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 55,077 | .00 | 0 |
| 2023-11-02 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 108,188 | .00 | 0 |
| 2023-06-08 | Scimeca Dario (General Counsel and Secretary) | Sale | 13,361 | .75 | 10,020 |
| 2023-06-07 | Barton Shane (VP & Corporate Controller) | Option Ex | 6,060 | .00 | 0 |
| 2023-06-07 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 31,771 | .00 | 0 |
| 2023-06-07 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 4,872 | .00 | 0 |
| 2023-06-07 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 47,726 | .00 | 0 |
| 2023-04-27 | List Alan (Chief Medical Officer) | Sale | 7,771 | .79 | 6,139 |
| 2023-04-26 | List Alan (Chief Medical Officer) | Option Ex | 26,027 | .00 | 0 |
| 2023-04-11 | Buehler Kevin (Director) | Option Ex | 5,701 | .00 | 0 |
| 2023-03-22 | Amoroso Michael (President and CEO) | Sale | 46,999 | .82 | 38,539 |
| 2023-03-21 | Amoroso Michael (President and CEO) | Option Ex | 102,535 | .00 | 0 |
| 2023-03-17 | Kelly John Alexander (Chief Financial Officer) | Buy | 20,000 | .86 | 17,200 |
| 2023-03-06 | List Alan (Chief Medical Officer) | Sale | 9,473 | 1.07 | 10,136 |
| 2023-03-06 | Scimeca Dario (General Counsel and Secretary) | Sale | 12,172 | 1.07 | 13,024 |
| 2023-03-03 | List Alan (Chief Medical Officer) | Option Ex | 29,453 | .00 | 0 |
| 2023-03-03 | Barton Shane (VP & Corporate Controller) | Option Ex | 12,722 | .00 | 0 |
| 2023-03-03 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 27,558 | .00 | 0 |
| 2023-03-03 | Smith J. Jefferson (Chief Research Officer) | Option Ex | 15,576 | .00 | 0 |
| 2023-03-03 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 51,071 | .00 | 0 |
| 2022-10-17 | Amoroso Michael (President and CEO) | Sale | 11,006 | 1.32 | 14,527 |
| 2022-10-15 | Amoroso Michael (President and CEO) | Option Ex | 24,208 | .00 | 0 |
| 2022-09-23 | Kelly John Alexander (Chief Financial Officer) | Buy | 8,200 | 1.23 | 10,086 |
| 2022-09-22 | Kelly John Alexander (Chief Financial Officer) | Buy | 37,037 | 1.34 | 49,629 |
| 2022-06-22 | Kelly John Alexander (Chief Financial Officer) | Buy | 33,784 | 1.50 | 50,676 |
| 2022-06-08 | Scimeca Dario (General Counsel and Secretary) | Sale | 9,833 | 2.06 | 20,255 |
| 2022-06-08 | Jantz Derek (Chief Scientific Officer) | Sale | 18,849 | 2.06 | 38,828 |
| 2022-06-07 | Barton Shane (VP & Corporate Controller) | Option Ex | 6,061 | .00 | 0 |
| 2022-06-07 | Scimeca Dario (General Counsel and Secretary) | Option Ex | 31,774 | .00 | 0 |
| 2022-06-07 | Jantz Derek (Chief Scientific Officer) | Option Ex | 41,744 | .00 | 0 |
| 2022-06-07 | Kelly John Alexander (Chief Financial Officer) | Option Ex | 47,728 | .00 | 0 |
| 2022-04-27 | List Alan (Chief Medical Officer) | Sale | 7,775 | 2.10 | 16,327 |
| 2022-04-26 | List Alan (Chief Medical Officer) | Option Ex | 26,035 | .00 | 0 |
| 2022-03-17 | Kelly John Alexander (Chief Financial Officer) | Buy | 16,677 | 3.08 | 51,365 |
| 2021-06-23 | Thomson David S. (Chief Operating Officer) | Sale | 30,000 | 10.65 | 319,500 |
| 2021-06-23 | Thomson David S. (Chief Operating Officer) | Option Ex | 30,000 | 1.18 | 35,400 |
| 2021-06-21 | Thomson David S. (Chief Operating Officer) | Sale | 15,000 | 10.77 | 161,550 |
| 2021-06-21 | Thomson David S. (Chief Operating Officer) | Option Ex | 15,000 | 1.18 | 17,700 |
| 2021-06-18 | Thomson David S. (Chief Operating Officer) | Sale | 10,000 | 11.00 | 110,000 |
| 2021-06-18 | Thomson David S. (Chief Operating Officer) | Option Ex | 10,000 | 1.18 | 11,800 |
| 2021-06-17 | Thomson David S. (Chief Operating Officer) | Sale | 10,000 | 10.44 | 104,400 |
| 2021-06-17 | Thomson David S. (Chief Operating Officer) | Option Ex | 10,000 | 1.18 | 11,800 |
| 2021-06-15 | Thomson David S. (Chief Operating Officer) | Sale | 2,858 | 11.20 | 32,009 |
| 2021-06-15 | Thomson David S. (Chief Operating Officer) | Option Ex | 2,858 | 1.18 | 3,372 |
| 2021-06-11 | Thomson David S. (Chief Operating Officer) | Sale | 30,000 | 11.52 | 345,600 |
| 2021-06-11 | Thomson David S. (Chief Operating Officer) | Option Ex | 30,000 | 1.18 | 35,400 |
| 2021-05-17 | Jantz Derek (Chief Scientific Officer) | Sale | 20,000 | 9.38 | 187,600 |
| 2021-05-14 | Jantz Derek (Chief Scientific Officer) | Sale | 9,673 | 9.17 | 88,701 |
| 2021-05-14 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-05-13 | Kane Matthew R. (President and CEO) | Sale | 9,675 | 8.96 | 86,688 |
| 2021-05-13 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-05-10 | Kane Matthew R. (President and CEO) | Sale | 9,746 | 8.25 | 80,404 |
| 2021-05-10 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-05-07 | Kane Matthew R. (President and CEO) | Sale | 9,742 | 8.57 | 83,488 |
| 2021-05-07 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-04-21 | Kane Matthew R. (President and CEO) | Option Ex | 13,422 | 1.18 | 15,837 |
| 2021-04-16 | Jantz Derek (Chief Scientific Officer) | Sale | 9,675 | 8.84 | 85,527 |
| 2021-04-16 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-04-15 | Jantz Derek (Chief Scientific Officer) | Sale | 9,676 | 8.76 | 84,761 |
| 2021-04-15 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-04-12 | Kane Matthew R. (President and CEO) | Sale | 9,741 | 8.67 | 84,454 |
| 2021-04-12 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-04-09 | Kane Matthew R. (President and CEO) | Sale | 9,737 | 8.87 | 86,367 |
| 2021-04-09 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-04-08 | Kane Matthew R. (President and CEO) | Sale | 9,736 | 9.00 | 87,624 |
| 2021-04-08 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-18 | Jantz Derek (Chief Scientific Officer) | Sale | 9,665 | 11.08 | 107,088 |
| 2021-03-18 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-17 | Jantz Derek (Chief Scientific Officer) | Sale | 9,665 | 10.92 | 105,541 |
| 2021-03-17 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-16 | Jantz Derek (Chief Scientific Officer) | Sale | 9,661 | 11.97 | 115,642 |
| 2021-03-16 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-12 | Kane Matthew R. (President and CEO) | Sale | 9,712 | 11.36 | 110,328 |
| 2021-03-12 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-11 | Kane Matthew R. (President and CEO) | Sale | 9,711 | 11.38 | 110,511 |
| 2021-03-11 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-03-10 | Kane Matthew R. (President and CEO) | Sale | 9,710 | 11.79 | 114,480 |
| 2021-03-10 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-22 | Jantz Derek (Chief Scientific Officer) | Sale | 9,660 | 12.04 | 116,306 |
| 2021-02-22 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-19 | Jantz Derek (Chief Scientific Officer) | Sale | 9,663 | 11.55 | 111,607 |
| 2021-02-19 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-18 | Kane Matthew R. (President and CEO) | Sale | 9,705 | 12.23 | 118,692 |
| 2021-02-18 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-18 | Jantz Derek (Chief Scientific Officer) | Sale | 6,871 | 12.20 | 83,826 |
| 2021-02-18 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-17 | Kane Matthew R. (President and CEO) | Sale | 9,705 | 12.28 | 119,177 |
| 2021-02-17 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-02-16 | Kane Matthew R. (President and CEO) | Sale | 9,697 | 13.30 | 128,970 |
| 2021-02-16 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-01-29 | Jantz Derek (Chief Scientific Officer) | Sale | 6,444 | 12.25 | 78,939 |
| 2021-01-29 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,515 | .04 | 860 |
| 2021-01-28 | Jantz Derek (Chief Scientific Officer) | Sale | 6,444 | 11.97 | 77,134 |
| 2021-01-28 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-01-27 | Jantz Derek (Chief Scientific Officer) | Sale | 7,048 | 11.68 | 82,320 |
| 2021-01-27 | Jantz Derek (Chief Scientific Officer) | Option Ex | 21,514 | .04 | 860 |
| 2021-01-26 | Kane Matthew R. (President and CEO) | Sale | 9,697 | 13.37 | 129,648 |
| 2021-01-26 | Kane Matthew R. (President and CEO) | Option Ex | 21,515 | .04 | 860 |
| 2021-01-25 | Kane Matthew R. (President and CEO) | Sale | 9,695 | 13.74 | 133,209 |
| 2021-01-25 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-01-22 | Kane Matthew R. (President and CEO) | Sale | 10,218 | 13.53 | 138,249 |
| 2021-01-22 | Kane Matthew R. (President and CEO) | Option Ex | 21,514 | .04 | 860 |
| 2021-01-21 | Thomson David S. (Chief Operating Officer) | Sale | 10,000 | 16.49 | 164,899 |
| 2020-06-15 | Ansari Abid (Chief Financial Officer) | Option Ex | 8,783 | 1.20 | 10,539 |
| 2020-05-15 | Ansari Abid (Chief Financial Officer) | Option Ex | 9,661 | 1.19 | 11,496 |
| 2020-04-14 | Jantz Derek (Chief Scientific Officer) | Option Ex | 4,392 | 1.18 | 5,182 |
| 2020-01-06 | Ansari Abid (Chief Financial Officer) | Option Ex | 20,200 | 1.19 | 24,038 |
| 2019-12-19 | Heery Christopher (Chief Medical Officer) | Buy | 2,485 | 12.09 | 30,031 |
| 2019-09-23 | Kane Matthew R. (President and CEO) | Option Ex | 10,000 | 1.18 | 11,800 |
| 2019-09-10 | Jantz Derek (Chief Scientific Officer) | Option Ex | 13,176 | 1.18 | 15,547 |
| 2019-06-10 | Thomson David S. (Chief Development Officer) | Option Ex | 117,113 | 1.18 | 138,193 |
| 2019-06-10 | Ansari Abid (Chief Financial Officer) | Option Ex | 103,645 | 1.19 | 123,337 |
| 2019-04-03 | Yao Tony Dung Ling (Director) | Buy | 6,487 | 15.42 | 100,029 |
| 2019-04-01 | Goodman Corey S (10% Owner) | Buy | 50,000 | 16.00 | 800,000 |
| 2019-04-01 | Fmr Llc (Other) | Buy | 50,000 | 16.00 | 800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of DTIL listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Precision Biosciences Inc (symbol DTIL,
CIK number 1357874) see
the Securities and Exchange Commission (SEC) website.